Teoresi Medtech s.r.l.

In 2024, Teoresi Group launched the MedTech division, which is the result of Teoresi's sustained investment in Lifesciences and the acquisition of MediCon Ingegneria (Bologna) in 2023.

Teoresi MedTech stems from Medicon‘s extensive expertise, accumulated over more than two decades of pioneering research and development in both hardware and software solutions for medical devices. This heritage now converges with the innovation and vision of the Teoresi Group, forming a center of excellence within the healthcare industry.

The payoff – “Leading advanced medical solutions” – declares the commitment to propose new standards of excellence in biomedical engineering, developing solutions that not only meet current market needs but also anticipate future challenges, thus contributing to defining new horizons of care and well-being.

From AI for electrocardiogram analysis and diagnostic support, to Computer Vision for tele-rehabilitation, to wearables for patient monitoring, the technological solutions developed by Teoresi MedTech aim to have a high social impact, keeping the patient at the center of all project phases.

• Our approach: we manage the entire product ideation and realization process until market entry, in compliance with required international standards, ensuring constant support even in subsequent phases. At Teoresi MedTech, the team is proficient in overseeing the entire design lifecycle: from defining requirements to post-market maintenance. Our product specialists, with their biomedical expertise, ensure the quality of all stages of the product development process.

• Know-how: deep expertise in the biomedical field drives our Research and Development services in healthcare innovation. This allows us to provide support in bringing high-quality medical devices and healthcare applications to market (devices for autotrasfusion, apheresis, hemodialysis, laser surgery, electroneurography, electromyography, muscular electrostimulation, diathermy, transcutaneous electrical nerve stimulation equipments, sensors for blood property, and wearables, e-health, surgical robots, dental units)

• Production: thanks to high operational flexibility and an effective organizational structure, we are able to handle variable productions from small batches to volumes of thousands of devices per month. With a production department, like the rest of the company, certified ISO 13485, we can ensure compliance with regulations in the biomedical sector and the highest reliability of products and processes.

Teoresi MedTech Info:

Headquarters: Via Dei Trattati Comunitari Europei 1957-2007, 15 – 40127 Bologna (IT)

Operative location: Via E. Mattei, 20 40054 Budrio, BO (IT)

www.teoresigroup.com/company/medtech

--------------------------------------------------------------------

Teoresi Group

Teoresi was founded in 1987 in Turin as an IT consulting company. Today, the Teoresi Group is an international engineering company with 27 offices in four countries. In addition to its 15 offices in Italy - Turin, Milan, Modena, Rome and Naples - Teoresi also has four German locations: Munich, Stuttgart, Berlin and Ingolstadt. In Switzerland, Teoresi has offices in Lugano and Basel.

Teoresi helps companies to develop projects with cutting-edge technologies: These range from self-driving cars to nanotechnology for the life sciences. Drawing on its extensive technical expertise, the group offers design, development and technology consulting services focussing on the innovative aspects of each project challenge. Teoresi supports clients from analysis to final product conception, from design idea to prototype, from prototype to market launch.

Teoresi is Engineering for human life: through our work, we like to generate opportunities for the people and for the Planet.

“We believe in a sustainable innovation for the preservation of life, environment and social inclusion”.

Teoresi Group Info:

Headquarters: Via Perugia 24, 10152 Torino (IT)

www.teoresigroup.com